GWM
RPRX icon

Geneos Wealth Management’s Royalty Pharma RPRX Stock Holding History

Geneos Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104
Closed -$4.02K – 2551
2025
Q4 		$4.02K Buy
104
+65
+167% +$2.48K ﹤0.01% 2198
2025
Q3 		$1.38K Sell
39
-340
-90% -$12.3K ﹤0.01% 2370
2025
Q2 		$13.7K Sell
379
-580
-60% -$19.2K ﹤0.01% 2195
2025
Q1 		$29.9K Buy
959
+809
+539% +$25.6K ﹤0.01% 2151
2024
Q4 		$3.83K Sell
150
-12
-7% -$318 ﹤0.01% 2418
2024
Q3 		$4.58K Buy
+162
New +$4.49K ﹤0.01% 2095

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $95.1B AUM 30.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return